Minimolide F exhibits potential as an anti-inflammatory agent, showing inhibitory activity against key inflammatory mediators in cellular models. It has been investigated for its ability to suppress pro-inflammatory cytokines, suggesting possible use in developing treatments for chronic inflammatory conditions. Additionally, preliminary studies indicate antimicrobial properties, particularly against Gram-positive bacteria, making it a candidate for antibiotic research. Its unique macrocyclic structure also makes it of interest in drug design for improving metabolic stability and target specificity.